# MANKIND share price, delivery % and history — Mankind Pharma Limited

> Delivery percentage for Mankind Pharma Limited (MANKIND) against its own history, with 845 sessions of split-adjusted NSE data from 2023 — plus moving averages, RSI and the 52-week range.

Canonical: https://patternsradar.com/s/MANKIND

NSE · equity · [Healthcare](https://patternsradar.com/stocks/sector/healthcare.md) · [Pharmaceuticals & Biotechnology](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md)

## Latest session

- Close: 2,503.8 INR (-1.62% on the day), 2026-09-30
- Delivery: 59.04% of volume taken to demat (20-day average 54.63%)
- Volume: 13.11L shares, turnover ₹328.3Cr
- Relative volume: 2.44× of its own 20-day average

## Technicals

- RSI(14): 59.4
- ATR(14): 63.95
- SMA 50: 2,417.53, SMA 200: 2,292
- 52-week range: 1,909.7 – 2,642 (-5.23% from the high)

## Performance

- 1 week 1.57%, 1 month 3.5%, 3 months 0.68%
- 6 months 22.81%, 1 year -2.36%

## Delivery percentage

- Latest: 59.04% (2026-09-30)
- 20-day average: 54.63%
- 1-year average: 55.79%
- Percentile against its own history: 55th
- Range: 7.52% – 93.9% across 845 sessions with a reading

Over the last 20 sessions MANKIND settled 54.6% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 55.8%. The latest session ranks higher than 55% of the 845 sessions on record for it.

[What delivery percentage measures](https://patternsradar.com/learn/delivery-percentage.md). [Scan the whole market on delivery](https://patternsradar.com/scans/delivery.md).

## Fundamentals

- Market cap: 1,03,418.2 crore
- P/E (TTM): 50.02 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 50.06 INR, split-adjusted to match the price series
- Revenue growth: 12.89% YoY, 17.07% QoQ
- Profit growth: 29.12% YoY, 2.62% QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 2y | 17.64% | 1.91% |

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 3,076.5 | 2,339.2 | 846.8 | 658.9 | 16.31 | 21.42% |
| 2024-12-31 | 3,230 | 2,813.4 | 493.9 | 384.5 | 9.45 | 11.9% |
| 2025-03-31 | 3,079.4 | 2,817.6 | 513.1 | 424.7 | 10.19 | 13.79% |
| 2025-06-30 | 3,570.4 | 3,112.9 | 537.3 | 444.6 | 10.62 | 12.45% |
| 2025-09-30 | 3,697.2 | 3,167.3 | 621.7 | 520.2 | 12.39 | 14.07% |
| 2025-12-31 | 3,567.2 | 3,027.6 | 505.8 | 413.9 | 9.9 | 11.6% |
| 2026-03-31 | 3,442.9 | 2,877.9 | 656.2 | 559.4 | 13.44 | 16.25% |
| 2026-06-30 | 4,030.6 | 3,310.1 | 765.5 | 574.1 | 13.76 | 14.24% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 72.63%
- Public: 27.37%
- FII: 9.45%, DII: 15.39%
- Promoter shares pledged: 0%

## Recent filings

- 2026-07-30: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_180913_30072026201521_iXBRL_WEB.html
- 2026-07-21: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1697698_21072026100612_WEB.xml
- 2026-05-19: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_159109_19052026232346_iXBRL_WEB.html
- 2026-04-20: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1654490_20042026103025_WEB.xml
- 2026-02-03: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_139966_03022026193712_iXBRL_WEB.html
- 2026-01-13: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1599426_13012026121802_WEB.xml
- 2025-11-06: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_124984_06112025213525_iXBRL_WEB.html
- 2025-10-14: shareholding for 2025-09-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1547509_14102025034730_WEB.xml

Dated by the day the company broadcast the filing. 30 events are indexed for this instrument.

## About the instrument

- Listed: 2023-05-09 — latest session 2026-09-30 (845 sessions)
- ISIN: INE634S01028
- Series: EQ
- Liquidity rank: #237 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

## More in Pharmaceuticals & Biotechnology

- [DIVISLAB](https://patternsradar.com/s/DIVISLAB.md) — Divi's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [LAURUSLABS](https://patternsradar.com/s/LAURUSLABS.md) — Laurus Labs Limited (Pharmaceuticals & Biotechnology)
- [WOCKPHARMA](https://patternsradar.com/s/WOCKPHARMA.md) — Wockhardt Limited (Pharmaceuticals & Biotechnology)
- [SUNPHARMA](https://patternsradar.com/s/SUNPHARMA.md) — Sun Pharmaceutical Industries Limited (Pharmaceuticals & Biotechnology)
- [MOREPENLAB](https://patternsradar.com/s/MOREPENLAB.md) — Morepen Laboratories Limited (Pharmaceuticals & Biotechnology)
- [DRREDDY](https://patternsradar.com/s/DRREDDY.md) — Dr. Reddy's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [SYMBIOTEC](https://patternsradar.com/s/SYMBIOTEC.md) — SYMBIOTEC (Pharmaceuticals & Biotechnology)
- [GLAND](https://patternsradar.com/s/GLAND.md) — Gland Pharma Limited (Pharmaceuticals & Biotechnology)
- [ZYDUSLIFE](https://patternsradar.com/s/ZYDUSLIFE.md) — Zydus Lifesciences Limited (Pharmaceuticals & Biotechnology)
- [TORNTPHARM](https://patternsradar.com/s/TORNTPHARM.md) — Torrent Pharmaceuticals Limited (Pharmaceuticals & Biotechnology)
- [LUPIN](https://patternsradar.com/s/LUPIN.md) — Lupin Limited (Pharmaceuticals & Biotechnology)
- [AHCL](https://patternsradar.com/s/AHCL.md) — Anlon Healthcare Limited (Pharmaceuticals & Biotechnology)

[All Pharmaceuticals & Biotechnology stocks on the NSE](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md) · [All Healthcare stocks on the NSE](https://patternsradar.com/stocks/sector/healthcare.md)

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/MANKIND.

---

Price and delivery data from the [eod2](https://github.com/BennyThadikaran/eod2) dataset: National Stock Exchange of India end-of-day files, split- and bonus-adjusted, updated after each close. Not affiliated with or endorsed by NSE. PatternsRadar is a research tool. Nothing here is investment advice or a recommendation to buy or sell anything.